You are here: Home › News Room › ASX Announcements

ASX Announcements

Also in News Room:

Date	Name	Filesize
Dec 23, 2011	Form 603 and 604	(239 KB)
Dec 16, 2011	Allied Healthcare Featured on BoardRoom Radio following positive Tissue Heart Valve study results	(188 KB)
Dec 7, 2011	Allied Healthcare Group Appoints Dr Julian Chick to Executive Team	(160 KB)
Dec 6, 2011	Options Expiry Notice	(154 KB)
Dec 5, 2011	Allied Healthcare Demonstrates Positive Results in Tissue Heart Valve Study	(557 KB)
Dec 1, 2011	Appendix 3Y – Change in Director’s Interest Notice	(276 KB)
Dec 1, 2011	Appendix 3B – Issue of Shares	(406 KB)
Dec 1, 2011	Bell Potter Securities Research Coverage	(108 KB)
Nov 29, 2011	Allied Healthcare Group AGM Presentation November 2011	(368 KB)
Nov 29, 2011	Results of Annual General Meeting November 2011	(333 KB)
Nov 22, 2011	Allied Healthcare Group Appoints a New CEO of Celxcel	(332 KB)
Oct 31, 2011	Appendix 4C - Quarterly Report	(526 KB)
Oct 27, 2011	Notice of AGM	(517 KB)
Oct 20, 2011	Changes and Company Secretary Appointment-Resignation	(312 KB)
Oct 20, 2011	Appendix 3B – Issue of Unlisted Options	(407 KB)
Oct 18, 2011	Sale of Unmarketable Parcels	(423 KB)
Oct 18, 2011	Replacement Initial Director's Interest Notice	(212 KB)
Oct 18, 2011	Replacement Change of Director`s Interest Notice	(295 KB)
Oct 18, 2011	Notice of Breach of Listing Rules	(418 KB)
Oct 14, 2011	Appendix 3B	(341 KB)
Oct 14, 2011	Correction to Appendix 3B	(342 KB)
Oct 12, 2011	Allied Healthcare Increases Holding in DNA Vaccine Developer Coridon	(315 KB)
Oct 11, 2011	Coridon Demonstrates 100% Protection against Herpes Simplex Virus 2 using DNA vaccine	(121 KB)
Oct 5, 2011	Appendix 3B	(357 KB)
Sep 30, 2011	Allied Healthcare Announces a $5M Equity Funding Package	(144 KB)
Sep 28, 2011	Trading Halt	(25 KB)
Sep 15, 2011	Appendix 3Y – Change in Director’s Interest Notice	(88 KB)
Sep 2, 2011	Appendix 3B - Issue of Unlisted Options	(186 KB)
Sep 1, 2011	Financial Results	(442 KB)
Aug 29, 2011	Allied Healthcare’s Celxcel Granted Tissue Engineering Patent	(239 KB)
Aug 5, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jul 29, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jul 22, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jul 22, 2011	Notice of Ceasing to be a Substantial Holder	(207 KB)
Jul 20, 2011	DNA Vaccine Developer Coridon in US Collaboration	(243 KB)
Jul 19, 2011	Notice of Inital Substantial Holder	(1 MB)
Jul 18, 2011	The Metal Group - Notice of Initial Substantial Holder	(489 KB)
Jul 14, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jul 14, 2011	Avexa Limited – Notice of Initial Substantial Holder	(165 KB)
Jul 8, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jul 1, 2011	Allied Healthcare Group Address Change and New ASX Code	(164 KB)
Jul 1, 2011	Appendix 3B - Exercise of Options	(186 KB)
Jun 29, 2011	bioMD Announces Name Change to Allied Healthcare Group	(186 KB)
Jun 24, 2011	bioMD Bid for Allied Medical Closes, Compulsory Acquisition Commences	(1004 KB)
Jun 20, 2011	bioMD Announces Changes to the Board	(185 KB)
Jun 15, 2011	Appendix 3B – Exercise of Options	(112 KB)
Jun 10, 2011	Results of General Meeting	(83 KB)
Jun 3, 2011	Market Update - Heart Valve Study	(181 KB)
May 31, 2011	Takeover Notice to Target 75 Percent	(120 KB)
May 26, 2011	Takeover Notice to Target 50 Percent	(130 KB)
May 17, 2011	Takeover Notice to Target 25 Percent	(138 KB)
May 11, 2011	Notice of Meeting with Proxy	(604 KB)
May 4, 2011	Appendix 3B - Exercise of Options	(113 KB)
May 4, 2011	Allied Medical Target's Statement	(3 MB)
May 3, 2011	Off Market Takeover Bid for Allied Medical Ltd	(836 KB)
May 3, 2011	bioMD Lodges Bidders Statement for Offer for Unlisted Allied Medical	(78 KB)
Apr 28, 2011	Appendix 4C Quarterly Report	(228 KB)
Apr 14, 2011	Market Update - Takeover	(43 KB)
Mar 21, 2011	Lapse of Options	(79 KB)
Mar 15, 2011	Appendix 3B - Exercise of Options	(112 KB)
Mar 9, 2011	Market Update - Tissue Heart Valve Study	(900 KB)
Feb 28, 2011	bioMD Half Yearly Report	(291 KB)
Feb 24, 2011	Allied Medical Ltd takeover UPDATE	(154 KB)
Feb 17, 2011	Appendix 3B	(119 KB)
Feb 15, 2011	Reinstatement to Official Quotation	(10 KB)
Feb 15, 2011	Clarification on ASX Lodgement Error	(80 KB)
Feb 15, 2011	bioMD Makes Offer for Unlisted Allied Medical Ltd	(96 KB)
Feb 14, 2011	Suspension from Official Quotation	(112 KB)
Feb 10, 2011	Trading Halt	(75 KB)
Feb 8, 2011	Southern Cross Annoucement	(178 KB)
Feb 8, 2011	Research Coverage - Southern Cross Equities	(206 KB)
Jan 27, 2011	Appendix 4C Quarterly Report	(228 KB)

Top ↑

Date	Name	Filesize
Dec 24, 2010	Securities Trading Policy	(147 KB)
Dec 23, 2010	Details of Company Address	(81 KB)
Nov 16, 2010	Lapse of Options	(79 KB)
Nov 10, 2010	Results of Meeting	(71 KB)
Nov 10, 2010	Chairman's Address to Shareholders	(106 KB)
Nov 1, 2010	Successful First Milestone	(74 KB)
Oct 28, 2010	Appendix 4C Quarterly Report	(194 KB)
Oct 6, 2010	Notice of Meeting	(382 KB)
Sep 28, 2010	Resignation and Appointment of Company Secretary	(68 KB)
Sep 1, 2010	Lapse of Options	(76 KB)
Sep 1, 2010	Appendix 3B - Allotment	(127 KB)
Aug 23, 2010	Financial Results	(298 KB)
Aug 17, 2010	Options Lapse	(76 KB)
Jul 19, 2010	June Quarterly	(125 KB)
Jul 7, 2010	Appendix 3B - Allotment	(127 KB)
Jul 1, 2010	BODOA - Options Expiring 31 Dec 2011	(76 KB)
Jun 29, 2010	Appendix 3B - Allotment	(127 KB)
May 31, 2010	Appendix 3B - Allotment	(128 KB)
May 28, 2010	Appendix 3Y Change in Director's Notice	(92 KB)
May 13, 2010	Appendix 3B - Allotment	(128 KB)
May 5, 2010	Appendix 3B - Allotment	(128 KB)
May 4, 2010	Feasibilty	(78 KB)
Apr 28, 2010	Trial	(78 KB)
Apr 12, 2010	Change of Director's Interest	(95 KB)
Apr 12, 2010	Allotment of New Options	(133 KB)
Apr 8, 2010	SA Trial 12 Months	(82 KB)
Apr 7, 2010	Right's Issue - Notification of Shortfall	(79 KB)
Mar 30, 2010	Retraction	(79 KB)
Mar 30, 2010	Offer Extention	(79 KB)
Mar 25, 2010	Hernia 12 Month Explants	(203 KB)
Mar 17, 2010	Offer Document Despatch	(78 KB)
Mar 12, 2010	NAMSA Update	(86 KB)
Mar 3, 2010	Right's Issue Timetable Amended	(76 KB)
Mar 2, 2010	Research Coverage - Southern Cross Equities	(72 KB)
Mar 2, 2010	Amended Appendix 3B	(128 KB)
Feb 26, 2010	Right's Issue - Notification of Letters to Security Holders	(175 KB)
Feb 25, 2010	Trading Halt	(27 KB)
Feb 12, 2010	Appendix 4D Half Year Report	(198 KB)
Feb 4, 2010	Change in Substantial Holder	(87 KB)
Feb 4, 2010	Appendix 3Y Change in Director's Interest	(90 KB)

Date	Name	Filesize
Dec 15, 2009	NAMSA Biocompatibility Testing	(76 KB)
Dec 10, 2009	Results of Extraordinary General Meeting	(76 KB)
Nov 12, 2009	Amended EGM Notice	(315 KB)
Nov 11, 2009	Results of Extraordinary General Meeting	(76 KB)
Nov 11, 2009	Chairman's Address	(109 KB)
Nov 9, 2009	Gynecel Trial	(91 KB)
Oct 26, 2009	Appendix 3B Neethling Options	(165 KB)
Oct 15, 2009	Quarterly Report - September 2009	(140 KB)
Oct 7, 2009	Notice of Meeting	(317 KB)
Aug 27, 2009	Appendix 4E	(485 KB)
Aug 26, 2009	Sydney Ethics Approval	(88 KB)
Jul 23, 2009	Quarterly Report - June 2009	(521 KB)
Jul 17, 2009	Boardroom Radio Broadcast	(80 KB)
Jul 16, 2009	Six Monthly Milestone Achieved	(124 KB)
Jul 10, 2009	Boardroom Radio Broadcast	(80 KB)
Jul 8, 2009	South African Patent	(88 KB)
Jul 6, 2009	South African Patent	(88 KB)
Jun 25, 2009	World Heart Valve Meeting	(72 KB)
Jun 12, 2009	Change of Substantial Holder - Mandolin	(87 KB)
Jun 12, 2009	Change of Substantial Holder - Parerg	(94 KB)
Jun 12, 2009	Change of Director's Interest Notice	(90 KB)
Jun 12, 2009	Boardroom Radio Broadcast	(84 KB)
Jun 10, 2009	ADAPT Tissue Assessment - Harvard Medical School	(57 KB)
Jun 10, 2009	ADAPT Tissue Assessment Annoucement	(73 KB)
May 11, 2009	Initial Substantial Holder	(259 KB)
May 5, 2009	Right's Issue - Notification of Shortfall	(152 KB)
May 1, 2009	Shortfall Announcement	(95 KB)
Apr 30, 2009	Quarterly Report - March 2009	(604 KB)
Apr 7, 2009	Change of Substantial Holder Notice	(99 KB)
Apr 7, 2009	Change of Substantial Holder Notice	(105 KB)
Apr 7, 2009	Change in Substantial Holder	(87 KB)
Apr 7, 2009	Appendix 3Y – Change in Director’s Interest Notice	(100 KB)
Apr 6, 2009	Appendix 3B - Right's Issue	(163 KB)
Apr 1, 2009	Right's Issue, Closure	(81 KB)
Mar 9, 2009	Bioshares Coverage	(79 KB)
Feb 27, 2009	Propsectus Despatch	(78 KB)
Feb 16, 2009	Right's Issue - Notification of Letters to Security Holders	(188 KB)
Feb 13, 2009	Boardroom Radio Broadcast	(80 KB)
Feb 6, 2009	Appendix 4D Half Year Report	(183 KB)
Feb 2, 2009	Lapse of unlisted Options	(75 KB)
Jan 30, 2009	Change in Substantial Holder	(87 KB)
Jan 29, 2009	Appendix 3Y – Change in Director’s Interest Notice	(32 KB)
Jan 21, 2009	Change of Director's Interest Notice	(32 KB)
Jan 8, 2009	Appendix 4C - Quarterly Report	(92 KB)

Date	Name	Filesize
Nov 12, 2008	Chairman's Address	(90 KB)
Nov 12, 2008	Results of Annual General Meeting	(29 KB)
Nov 3, 2008	Lapse of unlisted Options	(31 KB)
Oct 9, 2008	Phase II Clinical Trial Update	(340 KB)
Oct 7, 2008	Notice of Annual Meeting and Proxy Form	(270 KB)
Aug 12, 2008	Appendix 4E - Preliminary Final Report for the year ended 30 June 2008	(362 KB)
Jul 22, 2008	Research Coverage	(275 KB)
May 1, 2008	Human Trial of 'Cardiocel'	(589 KB)
Apr 11, 2008	Appendix 4C - Quarterly Report	(676 KB)
Apr 4, 2008	Research Coverage	(277 KB)
Apr 1, 2008	Change of Substantial Holder Notice	(67 KB)
Apr 1, 2008	Change of Director's Interest Notice	(44 KB)
Mar 20, 2008	Appendix 3B - Issue of Employee Options	(181 KB)
Mar 7, 2008	TGA Inclusion	(229 KB)
Feb 12, 2008	Appendix 4D - Half Yearly Report	(283 KB)
Feb 4, 2008	Change of Director's Interest Notice	(44 KB)
Jan 25, 2008	Change of Substantial Holder Notice	(69 KB)
Jan 23, 2008	Change of Director's Interest Notice	(44 KB)
Jan 22, 2008	Change of Director's Interest Notice	(44 KB)
Jan 18, 2008	Change of Director's Interest Notice	(44 KB)
Jan 15, 2008	Appendix 4C - Quarterly Report	(227 KB)
Jan 11, 2008	Change of Director's Interest Notice	(44 KB)

Date	Name	Filesize
Aug 7, 2008	Option Expiry Letter	(49 KB)
Dec 21, 2007	Appendix 3Y - Change in Directors Notice	(44 KB)
Dec 18, 2007	Top 20 Shareholders	(47 KB)
Dec 18, 2007	Change of Substantial Holder Notice	(69 KB)
Dec 18, 2007	Change of Substantial Holder Notice - Amended	(68 KB)
Dec 18, 2007	Change of Director's Interest Notice	(44 KB)
Dec 18, 2007	Change of Director's Interest Notice - Amended	(45 KB)
Dec 17, 2007	Change of Substantial Holder Notice	(65 KB)
Dec 17, 2007	Change in Director's Notice	(53 KB)
Dec 17, 2007	Change in Director's Notice - Revised	(44 KB)
Dec 17, 2007	Appendix 3B for Issue of New Shares and Options Under Rights Issue	(165 KB)
Dec 7, 2007	TGA Inclusion	(189 KB)
Dec 3, 2007	Entitlements Issue Now Closed	(167 KB)
Nov 13, 2007	Agreement Signed with Royal Perth Hospital	(262 KB)
Nov 13, 2007	Results of Annual General Meeting	(178 KB)
Nov 13, 2007	Managing Director's Address	(405 KB)
Nov 13, 2007	Chairman's Address	(14 KB)
Oct 31, 2007	Non-Renounceable Issue Prospectus - Extention	(166 KB)
Oct 17, 2007	Quarterly Report - September 2007	(412 KB)
Oct 4, 2007	Research Coverage	(197 KB)
Oct 2, 2007	Results of Extraordinary General Meeting	(176 KB)
Sep 28, 2007	Notice of Annual Meeting and Proxy Form	(438 KB)
Sep 10, 2007	Results from a 12 Month Comparative Patch Study	(264 KB)
Sep 6, 2007	Non Renounceable Issue of New Shares and Attaching New Options	(163 KB)
Sep 6, 2007	ASIC Form 484 – Issue of Shares	(31 KB)
Sep 4, 2007	Notice of General Meeting	(237 KB)
Sep 4, 2007	Appendix 3B – Conversion of BODO Options	(160 KB)
Sep 3, 2007	Lapse of Options	(32 KB)
Aug 28, 2007	Appendix 4E - Preliminary Final Report for the year ended 30 June 2007	(499 KB)
Aug 22, 2007	Prospectus	(248 KB)
Aug 21, 2007	Appendix 3B and Timetable	(115 KB)
Aug 10, 2007	Appendix 3Y – Change in Director’s Interest Notice	(43 KB)
Aug 10, 2007	Change of Substantial Holder Notice	(68 KB)
Aug 9, 2007	New Issue of Securities	(39 KB)
Aug 7, 2007	Appendix 3Y – Change in Director’s Interest Notice	(43 KB)
Jul 31, 2007	Appendix 3Y – Change in Director’s Interest Notice	(43 KB)
Jul 31, 2007	Appendix 3Y – Change in Director’s Interest Notice	(44 KB)
Jul 30, 2007	Change of Director's Interest Notice	(44 KB)
Jul 26, 2007	Issue of Unlisted Options	(38 KB)
Jul 12, 2007	Approval of Human Clinical Trial of ADAPT® Treated Cardiovascular Patches	(181 KB)
Jun 27, 2007	Change of Substantial Holder Notice	(70 KB)
Jun 18, 2007	Change of Substantial Holder Notice	(69 KB)
Jun 15, 2007	Appendix 3Y – Change in Director’s Interest Notice	(44 KB)
Jun 13, 2007	Appendix 3B - Issue of Shares	(123 KB)
May 30, 2007	Human Clinical Trial of ADAPT® Treated Cardiovascular Patches	(180 KB)
May 25, 2007	ADAPT® Advanced Tissue Process Presentation	(175 KB)
May 8, 2007	bioMD Limited Acquires Additional Holding in Bioimplant Company - Celxcel Pty Ltd	(175 KB)
May 7, 2007	Appendix 3Y – Change in Director’s Interest Notice	(60 KB)
May 7, 2007	Appendix 3B – Issue of Shares under Share Purchase Plan	(60 KB)
May 4, 2007	Share Purchase Plan Completion	(178 KB)
Apr 19, 2007	Share Purchase Plan Continuation	(223 KB)
Apr 17, 2007	Appendix 4C - Quarterly Report	(316 KB)
Apr 11, 2007	Celxcel to Present at The Society for Heart Valve Disease 4th Biennial Meeting - New York June 15-18, 2007	(189 KB)
Mar 26, 2007	Share Purchase Plan - Letter to Shareholders	(341 KB)
Mar 16, 2007	Share Purchase Plan Offer	(149 KB)
Mar 14, 2007	Positive Results from a 200 Day Comparative Patch Study	(199 KB)
Feb 2, 2007	Half Yearly Report for the 6 months ended 31 December 2006	(178 KB)
Jan 22, 2007	Change of Director's Interest Notice	(44 KB)
Jan 17, 2007	Quarterly Report for the period ended 31 Dec 2006	(560 KB)
Jan 16, 2007	ADAPT® Preclinical Trial Produces Promising Results	(192 KB)

Date	Name	Filesize
Nov 20, 2006	Change of Director's Interest Notice	(66 KB)
Nov 16, 2006	2006 AGM Results	(15 KB)
Oct 30, 2006	Change of Substantial Holder Notice	(66 KB)
Oct 30, 2006	Appendix 3Y – Change in Director’s Interest Notice	(44 KB)
Oct 23, 2006	Quarterly Activities Report for period ending 30 September 2006	(720 KB)
Oct 9, 2006	Notice of Annual Meeting and Proxy Form	(296 KB)
Sep 4, 2006	bioMD Limited Achieves Breakthrough with Animal Tissue Implants	(109 KB)
Aug 28, 2006	Change of Director's Interest Notice	(36 KB)
Aug 25, 2006	Appendix 3B - Issue of Employee Options	(180 KB)
Aug 24, 2006	Appendix 4E - Final Report year ended 30 June 2006	(401 KB)
Aug 22, 2006	CSIRO Collaborative Research Agreement Proceeds to Stage II Phase 2	(148 KB)
Jul 18, 2006	Change of Substantial Holder Notice	(98 KB)
Jul 18, 2006	Change of Director's Interest Notice	(44 KB)
Jul 17, 2006	Lapse of unlisted Options	(17 KB)
Jul 17, 2006	Quarterly Activities Report for period ending 31 June 2006	(338 KB)
Jul 14, 2006	Change in Director's Notice	(44 KB)
Jul 12, 2006	Appendix 3Y – Change in Director’s Interest Notice	(43 KB)
Jul 10, 2006	bioMD Limited Acquired Additional 21.5% of Bioimplant CompanyCelxcel Pty Ltd	(256 KB)
Jun 30, 2006	Quarterly Report for three months ending 30 June 2006	(228 KB)
Jun 6, 2006	Lapse of unlisted Options	(33 KB)
Apr 27, 2006	Quarterly Activities Report for period ending 31 March 2006	(334 KB)
Mar 24, 2006	Appendix 3B – Quotation of shares from escrow	(119 KB)
Mar 14, 2006	US Patent Granted - Prefilled Safety Syringe	(144 KB)
Mar 8, 2006	Release of Shares from Escrow	(26 KB)
Feb 21, 2006	Celxcel's Pre-Clinical Animal Trial Accelerates Move to Phase 1 Human Clinical Trials	(193 KB)
Feb 20, 2006	Half Yearly Report for the 6 months ended 31 December 2005	(690 KB)
Feb 3, 2006	Change of Director's Interest Notice	(44 KB)
Jan 30, 2006	Quarterly Activities Report for period ending 31 December 2005	(655 KB)
Jan 30, 2006	Change of Director's Interest Notice	(44 KB)

Date	Name	Filesize
Nov 8, 2005	bioMD Acquires 50% Interest in Tissue Engineering Company	(72 KB)
Oct 21, 2005	2005 AGM Chairman's Address	(47 KB)
Oct 21, 2005	2005 AGM Results	(35 KB)
Oct 19, 2005	Quarterly Activities Report for period ending 30 September 2005	(98 KB)
Sep 14, 2005	CSIRO Collaborative Research Agreement Proceeds to Stage II Phase 2	(67 KB)
Aug 26, 2005	Appendix 4E - Preliminary Final Report for the year ended 30 June 2005	(243 KB)
Aug 22, 2005	Form 604 - Change of Substantial Holder Notice	(74 KB)
Aug 9, 2005	Appendix 3Y - Change in Director's Interest Notice	(45 KB)
Aug 1, 2005	Appendix 3Y - Change in Director's Interest Notice	(45 KB)
Jul 28, 2005	Appendix 3Y - Change in Director's Interest Notice	(45 KB)
Jul 26, 2005	Appendix 3Y - Change in Director's Interest Notice	(44 KB)
Jul 19, 2005	Appendix 3Y - Change in Director's Interest Notice	(44 KB)
May 27, 2005	Appendix 3B - Issue of Shares	(122 KB)
May 23, 2005	Appendix 3Y - Change in Director's Interest Notice	(44 KB)
May 12, 2005	Disclosure in December 2004 Interim Report	(62 KB)
Apr 12, 2005	Quarterly Activities Report for period ending 31 March 2005	(339 KB)
Feb 10, 2005	Prefilled Safety Syringe - Australian Patent Granted	(57 KB)
Feb 7, 2005	Prefilled Safety Syringe - European Patent Validated	(96 KB)
Feb 2, 2005	Appendix 3B - Issue of Employee Options	(182 KB)
Feb 1, 2005	Half Yearly Report (Appendix 4D) for the 6 months ended 31 December 2004	(114 KB)
Jan 25, 2005	Appendix 3Y - Change in Director's Interest	(43 KB)
Jan 21, 2005	bioMD/CSIRO sign Research Agreement	(62 KB)
Jan 10, 2005	Appendix 4C - Quarterly Report	(101 KB)

Date	Name	Filesize
Apr 20, 2005	Appendix 4C - Quarterly Report	(106 KB)
Dec 16, 2004	Appendix 3Y – Change in Director’s Interest Notice	(43 KB)
Dec 14, 2004	Appedix 3B - Unlisted Options	(50 KB)
Dec 8, 2004	Appendix 3Y – Change in Director’s Interest Notice	(125 KB)
Dec 1, 2004	Prefilled Safety Syringe - European Patent Granted	(95 KB)
Nov 29, 2004	Appendix 3Y – Change in Director’s Interest Notice	(125 KB)
Nov 24, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Nov 19, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Nov 18, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Nov 17, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Nov 9, 2004	Release of Shares from Escrow	(88 KB)
Nov 5, 2004	Release of Shares from Escrow	(17 KB)
Nov 5, 2004	Appendix 3Y – Change in Director’s Interest Notice	(73 KB)
Nov 5, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Nov 3, 2004	Release of Shares from Escrow	(28 KB)
Nov 3, 2004	Allotment of Options	(52 KB)
Nov 1, 2004	Release of Shares from Escrow	(28 KB)
Oct 29, 2004	Appendix 3B - Release of Escrow Shares	(122 KB)
Oct 28, 2004	Chairman's Address at Annual General Meeting	(43 KB)
Oct 28, 2004	Shortfall of Options	(26 KB)
Oct 28, 2004	Results of General Meeting	(91 KB)
Oct 22, 2004	Release of Shares from Escrow	(88 KB)
Oct 22, 2004	Appendix 3B - Release of Escrow Shares	(198 KB)
Oct 15, 2004	Release of Shares from Escrow	(88 KB)
Oct 6, 2004	Release of Shares from Escrow	(88 KB)
Oct 1, 2004	Appendix 4C - Quarterly Report	(185 KB)
Sep 24, 2004	Options Rights Issue - Revised Letter to Shareholders	(62 KB)
Sep 24, 2004	Notice of Annual General Meeting	(260 KB)
Sep 24, 2004	Annual Report 2004	(360 KB)
Sep 23, 2004	POP Safety Injection Needle - Prototype Completed	(70 KB)
Sep 21, 2004	Summary of Terms of Rights Issue	(82 KB)
Sep 21, 2004	Appendix 3B - Non-Renounceable Rights Issue of Options	(603 KB)
Sep 8, 2004	Closure and Sale of Unmarketable Parcel Election Notices	(88 KB)
Aug 18, 2004	Appendix 4E - Preliminary Final Report for the year ended 30 June 2004	(380 KB)
Aug 12, 2004	bioMD Limited becomes AS/NZS ISO 9001:2000 Certified	(99 KB)
Aug 10, 2004	bioMD Enters New Phase with the Appointment of Production Manager	(94 KB)
Jul 22, 2004	Sale of Unmarketable Parcels - Retention Notice	(68 KB)
Jul 16, 2004	Appendix 4C - Quarterly Report	(196 KB)
Jul 1, 2004	Change in Substantial Holder Notice	(120 KB)
May 14, 2004	Prefilled Safety Syringe prototype finalised	(37 KB)
May 12, 2004	Pop Safety Injection Needle 'One of a Kind' Advice from Patent Co-operation Treaty	(106 KB)
Apr 22, 2004	Completion of International Patent Applications for the POP Safety Injection Needle	(93 KB)
Apr 14, 2004	Appendix 3Y - Change of Director's Interest Notice	(115 KB)
Mar 24, 2004	Initial Substantial Holder	(112 KB)
Mar 24, 2004	Appendix 3X - Initial Directors Interests Notices	(97 KB)
Mar 22, 2004	bioMD Limited Admission to the Official ASX List	(21 KB)
Mar 8, 2004	bioMD Closes IPO Overscribed	(20 KB)

Date	Name	Filesize
Jan 31, 2012	Appendix 4C - Quarterly Report	(526 KB)
Jan 12, 2012	Lapse of Listed Options	(155 KB)
Jan 12, 2012	Appendix 3B	(384 KB)